These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34582650)

  • 41. Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia.
    Tuta M; Boc N; Brecelj E; Omejc M; Anderluh F; Ermenc AS; Peressutti AJ; Oblak I; Krebs B; Velenik V
    Radiol Oncol; 2019 Oct; 53(4):465-472. PubMed ID: 31652124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Control of hair cell development by molecular pathways involving Atoh1, Hes1 and Hes5.
    Su YX; Hou CC; Yang WX
    Gene; 2015 Mar; 558(1):6-24. PubMed ID: 25550047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
    J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma.
    Giovannini C; Gramantieri L; Minguzzi M; Fornari F; Chieco P; Grazi GL; Bolondi L
    Am J Pathol; 2012 Aug; 181(2):413-22. PubMed ID: 22705236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma.
    Gambichler T; Mohtezebsade S; Wieland U; Silling S; Höh AK; Dreißigacker M; Schaller J; Schulze HJ; Oellig F; Kreuter A; Stockfleth E; Stücker M; Bechara FG; Becker JC
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):43-49. PubMed ID: 27624714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.
    Caramés C; Cristobal I; Moreno V; Marín JP; González-Alonso P; Torrejón B; Minguez P; Leon A; Martín JI; Hernández R; Pedregal M; Martín MJ; Cortés D; García-Olmo D; Fernández MJ; Rojo F; García-Foncillas J
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Assessment of the risk factors relating to lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy and the clinical significance].
    Zhao Q; Shi X; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):1040-1043. PubMed ID: 27680075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct Roles of HES1 in Normal Stem Cells and Tumor Stem-like Cells of the Intestine.
    Goto N; Ueo T; Fukuda A; Kawada K; Sakai Y; Miyoshi H; Taketo MM; Chiba T; Seno H
    Cancer Res; 2017 Jul; 77(13):3442-3454. PubMed ID: 28536281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atonal homolog 1 protein stabilized by tumor necrosis factor α induces high malignant potential in colon cancer cell line.
    Fukushima K; Tsuchiya K; Kano Y; Horita N; Hibiya S; Hayashi R; Kitagaki K; Negi M; Itoh E; Akashi T; Eishi Y; Oshima S; Nagaishi T; Okamoto R; Nakamura T; Watanabe M
    Cancer Sci; 2015 Aug; 106(8):1000-7. PubMed ID: 26017781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
    Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
    PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
    Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
    Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
    Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
    Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Inoue Y; Mori K; Ide S; Imaoka H; Kawamura M; Mohri Y; Kusunoki M
    Int J Clin Oncol; 2016 Apr; 21(2):350-358. PubMed ID: 26370256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis.
    Han Y; Xue X; Jiang M; Guo X; Li P; Liu F; Yuan B; Shen Y; Guo X; Zhi Q; Zhao H
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):267-73. PubMed ID: 25193236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
    Yamamoto A; Toiyama Y; Okugawa Y; Saigusa S; Ide S; Fujikawa H; Hiro J; Yasuda H; Yoshiyama S; Ohi M; Araki T; Kusunoki M
    Oncology; 2019; 96(2):70-78. PubMed ID: 30227430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer.
    Xi HQ; Cui JX; Shen WS; Wu XS; Bian SB; Li JY; Song Z; Wei B; Chen L
    Oncol Rep; 2014 Jul; 32(1):181-8. PubMed ID: 24859092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients.
    Candy PA; Phillips MR; Redfern AD; Colley SM; Davidson JA; Stuart LM; Wood BA; Zeps N; Leedman PJ
    Br J Cancer; 2013 Aug; 109(4):1023-30. PubMed ID: 23900217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.